These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

900 related items for PubMed ID: 19333921

  • 1. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E, Rauchhaus U, Stavropoulos A, Endert G, Wendisch V, Benahmed AS, Giaglis S, Karras J, Lee S, Gaus H, Bennett CF, Williams RO, Sideras P, Panzner S.
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [Abstract] [Full Text] [Related]

  • 2. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
    Woods AM, Thompson SJ, Wooley PH, Panayi G, Klavinskis LS.
    Arthritis Rheum; 2005 Dec; 52(12):3761-71. PubMed ID: 16329091
    [Abstract] [Full Text] [Related]

  • 3. Treatment of experimental murine colitis with CD40 antisense oligonucleotides delivered in amphoteric liposomes.
    Arranz A, Reinsch C, Papadakis KA, Dieckmann A, Rauchhaus U, Androulidaki A, Zacharioudaki V, Margioris AN, Tsatsanis C, Panzner S.
    J Control Release; 2013 Feb 10; 165(3):163-72. PubMed ID: 23178664
    [Abstract] [Full Text] [Related]

  • 4. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.
    Arthritis Rheum; 2009 Apr 10; 60(4):1006-19. PubMed ID: 19333946
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4.
    Sarkar S, Tesmer LA, Hindnavis V, Endres JL, Fox DA.
    Arthritis Rheum; 2007 Jan 10; 56(1):89-100. PubMed ID: 17195211
    [Abstract] [Full Text] [Related]

  • 6. Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritis.
    Guéry L, Chiocchia G, Batteux F, Boissier MC, Fournier C.
    Gene Ther; 2001 Dec 10; 8(24):1855-62. PubMed ID: 11821939
    [Abstract] [Full Text] [Related]

  • 7. Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells.
    Zheng X, Suzuki M, Ichim TE, Zhang X, Sun H, Zhu F, Shunnar A, Garcia B, Inman RD, Min W.
    J Immunol; 2010 Jun 01; 184(11):6457-64. PubMed ID: 20435931
    [Abstract] [Full Text] [Related]

  • 8. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Hur W, Cho ML, Yoon SK, Kim SY, Ju JH, Jhun JY, Heo SB, Moon YM, Min SY, Park SH, Kim HY.
    Immunol Lett; 2006 Aug 15; 106(2):154-62. PubMed ID: 16793145
    [Abstract] [Full Text] [Related]

  • 9. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.
    Hartgring SA, Willis CR, Alcorn D, Nelson LJ, Bijlsma JW, Lafeber FP, van Roon JA.
    Arthritis Rheum; 2010 Sep 15; 62(9):2716-25. PubMed ID: 20499386
    [Abstract] [Full Text] [Related]

  • 10. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response.
    You X, Pan M, Gao W, Shiah HS, Tao J, Zhang D, Koumpouras F, Wang S, Zhao H, Madri JA, Baker D, Cheng YC, Yin Z.
    Arthritis Rheum; 2006 Mar 15; 54(3):877-86. PubMed ID: 16508970
    [Abstract] [Full Text] [Related]

  • 11. A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.
    Marinova-Mutafchieva L, Williams RO, Mauri C, Mason LJ, Walmsley MJ, Taylor PC, Feldmann M, Maini RN.
    Arthritis Rheum; 2000 Mar 15; 43(3):638-44. PubMed ID: 10728758
    [Abstract] [Full Text] [Related]

  • 12. Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice.
    Crosby JR, Guha M, Tung D, Miller DA, Bender B, Condon TP, York-DeFalco C, Geary RS, Monia BP, Karras JG, Gregory SA.
    J Pharmacol Exp Ther; 2007 Jun 15; 321(3):938-46. PubMed ID: 17389243
    [Abstract] [Full Text] [Related]

  • 13. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
    Tellander AC, Michaëlsson E, Brunmark C, Andersson M.
    J Autoimmun; 2000 Jun 15; 14(4):295-302. PubMed ID: 10882055
    [Abstract] [Full Text] [Related]

  • 14. Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis.
    Zuo L, Huang Z, Dong L, Xu L, Zhu Y, Zeng K, Zhang C, Chen J, Zhang J.
    Gut; 2010 Apr 15; 59(4):470-9. PubMed ID: 19951904
    [Abstract] [Full Text] [Related]

  • 15. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
    Khoury M, Louis-Plence P, Escriou V, Noel D, Largeau C, Cantos C, Scherman D, Jorgensen C, Apparailly F.
    Arthritis Rheum; 2006 Jun 15; 54(6):1867-77. PubMed ID: 16729293
    [Abstract] [Full Text] [Related]

  • 16. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM, Lowe L, Senices M, Wu PW, Sibley B, Leathurby Y, Brown TP, Nickerson-Nutter C, Keith JC, Collins M.
    Arthritis Rheum; 2007 Apr 15; 56(4):1152-63. PubMed ID: 17393408
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
    Gonzalez-Rey E, Chorny A, Varela N, O'Valle F, Delgado M.
    Arthritis Rheum; 2007 Feb 15; 56(2):531-43. PubMed ID: 17265488
    [Abstract] [Full Text] [Related]

  • 18. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine.
    Popov I, Li M, Zheng X, San H, Zhang X, Ichim TE, Suzuki M, Feng B, Vladau C, Zhong R, Garcia B, Strejan G, Inman RD, Min WP.
    Arthritis Res Ther; 2006 Feb 15; 8(5):R141. PubMed ID: 16911769
    [Abstract] [Full Text] [Related]

  • 19. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
    Khoury M, Escriou V, Courties G, Galy A, Yao R, Largeau C, Scherman D, Jorgensen C, Apparailly F.
    Arthritis Rheum; 2008 Aug 15; 58(8):2356-67. PubMed ID: 18668557
    [Abstract] [Full Text] [Related]

  • 20. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y, Usui T, Kobayashi S, Iguchi-Hashimoto M, Ito H, Yoshitomi H, Nakamura T, Shimizu M, Kawabata D, Yukawa N, Hashimoto M, Sakaguchi N, Sakaguchi S, Yoshifuji H, Nojima T, Ohmura K, Fujii T, Mimori T.
    Arthritis Rheum; 2009 Aug 15; 60(8):2294-303. PubMed ID: 19644886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.